ConductScience.org, home

Paper39596237

The Potential of Mesenchymal Stem/Stromal Cells in Diabetic Wounds and Future Directions for Research and Therapy-Is It Time for Use in Everyday Practice?

Sieńko D and 9 others. Int J Mol Sci, 2024. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. The Potential of Mesenchymal Stem/Stromal Cells in Diabetic Wounds and Future Directions for Research and Therapy-Is It Time for Use in Everyday Practice? Papers, record 39596237. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39596237

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Potential of Mesenchymal Stem/Stromal Cells in Diabetic Wounds and Future Directions for Research and Therapy-Is It Time for Use in Everyday Practice?
PubMed
Journal
Int J Mol Sci
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
1.53, provisional
iCite
Revised in PubMed
2024-12-04
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sieńko DDamianhttps://orcid.org/0000-0003-4762-8738
2Szabłowska-Gadomska IIlonahttps://orcid.org/0000-0002-8649-1503
3Nowak-Szwed AAnna
4Rudziński SStefanhttps://orcid.org/0000-0002-1122-5796
5Gofron MMaksymilianhttps://orcid.org/0009-0007-6738-1150
6Zygmunciak PPrzemysławhttps://orcid.org/0009-0004-1404-7544
7Lewandowska-Szumieł MMałgorzatahttps://orcid.org/0000-0002-7140-0541
8Zgliczyński WSWojciech Stanisław
9Czupryniak LLeszek
10Mrozikiewicz-Rakowska BBeatahttps://orcid.org/0000-0002-1160-9204

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Mesenchymal Stem CellsMajor topic
Mesenchymal Stem Cell TransplantationMajor topic
Diabetic FootMajor topic
Wound HealingMajor topic
Humans
Animals

References90

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137583902Cell-based medicinal products approved in the European Union: current evidence and perspectives.Front Pharmacol2023https://conductscience.org/library/papers/37583902PubMed
233789737Exosomes derived from human adipose mesenchymal stem cells attenuate hypertrophic scar fibrosis by miR-192-5p/IL-17RA/Smad axis.Stem Cell Res Ther2021https://conductscience.org/library/papers/33789737PubMed
334020253Mesenchymal stromal cells-derived extracellular vesicles alleviate systemic sclerosis via miR-29a-3p.J Autoimmun2021https://conductscience.org/library/papers/34020253PubMed
429867137Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy.Acta Pharmacol Sin2019https://conductscience.org/library/papers/29867137PubMed
532826167Intralesional allogeneic adipose-derived stem cells application in chronic diabetic foot ulcer: Phase I/2 safety study.Foot Ankle Surg2021https://conductscience.org/library/papers/32826167PubMed
619307751Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10.Exp Mol Med2009https://conductscience.org/library/papers/19307751PubMed
736049265Health economics of diabetic foot ulcer and recent trends to accelerate treatment.Foot (Edinb)2022https://conductscience.org/library/papers/36049265PubMed
838252384Exploring the Role of Mesenchymal Stem Cell-Derived Exosomes in Diabetic and Chemotherapy-Induced Peripheral Neuropathy.Mol Neurobiol2024https://conductscience.org/library/papers/38252384PubMed
933397467Overview of current adipose-derived stem cell (ADSCs) processing involved in therapeutic advancements: flow chart and regulation updates before and after COVID-19.Stem Cell Res Ther2021https://conductscience.org/library/papers/33397467PubMed
1034439553Pathophysiological Association between Diabetes Mellitus and Endothelial Dysfunction.Antioxidants (Basel)2021https://conductscience.org/library/papers/34439553PubMed
1137712174Adipose-Derived Mesenchymal Stem Cell-Derived Exosomes Biopotentiated Extracellular Matrix Hydrogels Accelerate Diabetic Wound Healing and Skin Regeneration.Adv Sci (Weinh)2023https://conductscience.org/library/papers/37712174PubMed
1238186790'Oxidative stress'-A new target in the management of diabetes mellitus.J Family Med Prim Care2023https://conductscience.org/library/papers/38186790PubMed
1332938916Deregulated immune cell recruitment orchestrated by FOXM1 impairs human diabetic wound healing.Nat Commun2020https://conductscience.org/library/papers/32938916PubMed
1429996912Stem cell therapy for diabetic foot ulcers: a review of preclinical and clinical research.Stem Cell Res Ther2018https://conductscience.org/library/papers/29996912PubMed
1536691473Secretome of Mesenchymal Stromal Cells as a Possible Innovative Therapeutic Tool in Facial Nerve Injury Treatment.Biomed Res Int2023https://conductscience.org/library/papers/36691473PubMed
1636970004Diabetic foot ulcer: A comprehensive review of pathophysiology and management modalities.World J Clin Cases2023https://conductscience.org/library/papers/36970004PubMed
1727250101Hypoxia and Reactive Oxygen Species Homeostasis in Mesenchymal Progenitor Cells Define a Molecular Mechanism for Fracture Nonunion.Stem Cells2016https://conductscience.org/library/papers/27250101PubMed
1837998356Neutrophils in Inflammatory Diseases: Unraveling the Impact of Their Derived Molecules and Heterogeneity.Cells2023https://conductscience.org/library/papers/37998356PubMed
1932720751Combination product of dermal matrix, human mesenchymal stem cells, and timolol promotes diabetic wound healing in mice.Stem Cells Transl Med2020https://conductscience.org/library/papers/32720751PubMed
2022029655Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing.Cytotherapy2012https://conductscience.org/library/papers/22029655PubMed

See all 90 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
41602831Advancements in mesenchymal stem cell therapy for chronic wounds: challenges, innovations, and future directions.Front Cell Dev Biol2025https://conductscience.org/library/papers/41602831PubMed
40654520Regenerative potential of PRP-based scaffolds in chronic wound healing: Mechanisms, advances, and therapeutic insights.Regen Ther2025https://conductscience.org/library/papers/40654520PubMed
40034318Unveiling distinctions between mesenchymal stromal cells and stem cells by single-cell transcriptomic analysis.Heliyon2025https://conductscience.org/library/papers/40034318PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39596237

GET https://conductscience.org/api/papers/v1/39596237/references?page=2